BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1159@pharmaconomics
DTSTAMP:20260707T005011Z
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
SUMMARY:TAK PDUFA — Oveporexton (TAK-861) (estimated date)
DESCRIPTION:The FDA's approval decision on Oveporexton (TAK-861) for narcolepsy type 1 is due ~ Sep 30\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1395064/000139506426000005/form6k_021026.htm\n\nTrack it: https://www.pharmaconomics.com/e/1159
URL:https://www.pharmaconomics.com/e/1159
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:TAK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR